Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Hits New 52-Week High – Here’s Why

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as $11.23 and last traded at $11.02, with a volume of 34213 shares changing hands. The stock had previously closed at $11.15.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.

Fresenius SE & Co. KGaA Trading Down 1.2 %

The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. The stock has a market capitalization of $24.62 billion, a PE ratio of 52.48 and a beta of 1.02. The business’s 50-day moving average is $9.87 and its two-hundred day moving average is $9.36.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, February 26th. The company reported $0.18 earnings per share for the quarter. The firm had revenue of $6.01 billion during the quarter. As a group, equities research analysts anticipate that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.